ETF Exchange > IBRN ETF
IBRN - ETF Fact Sheet
iShares Neuroscience and Healthcare ETF - USD
Fund Identification
Ticker
IBRN
ISIN
US46436E3532
Main Metrics
Price
$39.41Expense Ratio
0.47%AuM
$7.88MTracking Difference
-0.53%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Neuroscience and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
IBRN's historical prices, performance, and flows
1m returns
7.76%
1m flows
$2M
* Net total returns
All data as of 2 September 2026
The ETF Exchange is brought to you by
With data and analysis by
See all IBRN data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
IBRN's characteristics
Manager
Manager statistics
1801 funds, $6,524.74Bn in AUM
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
IBRN's exposure
Countries
USA
73.59%
Other
26.41%
Sectors
Healthcare
99.89%
Top 5 holdings
Dianthus Therapeutics, Inc.
5.45%
Xenon Pharmaceuticals, Inc.
4.83%
Praxis Precision Medicines, Inc.
4.72%
ACADIA Pharmaceuticals, Inc.
4.66%
Arrowhead Pharmaceuticals, Inc.
4.65%
Total holdings
69
Total weight of top 5
24.31%